This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Identify which index funds yield the strongest after-tax returns in 2024. Learn how tax considerations impact fund performance and retirement strategy.
28,085 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A government-contract windfall sparked a sharp rally in Viasat stock. This article breaks down the news, the technolo...
With the 2026 World Cup drawing millions to North America, specific ETFs positioned benefit from a sharp travel uptic...
As Kevin Warsh takes the helm, investors await his first Fed rate decision amid sticky inflation and a shifting economy.
Regulators in Spain are sending a clear message: there will be no extensions for the EU crypto licensing deadline. Th...
AI momentum has shifted, and Cerebras stock's volatility comes into sharper focus for investors. This guide breaks do...
Celebrity dating rumors can ping our finances in surprising ways. This piece breaks down practical money skills you c...
Bitcoin jumped to a monthly high as geopolitical tensions escalated, gaining more than $10,000 from weekend lows. Ana...
Breaking news: the U.S. says it has hit military targets on Kharg Island in Iran, escalating a regional clash. Market...
A high-profile legal clash over concert logistics shines a light on how money moves in the music business. This artic...
A viral Met Gala moment isn't just fashion news. It can ripple into earnings, sponsorships, and long-term financial p...
Public statements by leaders can influence how homeowners think about safety and money. This piece digs into the fina...